Institution Directory

Clinical trials at UCSF

Sites in San Francisco, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1397

Shown on this page

Current sort

Live official records

Conditions: Pregnancy, Labor and Delivery, Labor Analgesia
Interventions: Ropivacaine + Fentanyl; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pancreatic Neuroendocrine Neoplasm
Interventions: Hereditary Cancer Panel; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • San Diego, California • San Francisco, California

Conditions: Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Artery Disease, Coronary Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 84 Years
Enrollment: 2,314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 3
States / cities: San Francisco, California • Chicago, Illinois • New York, New York

Conditions: Relapsing Multiple Sclerosis, Clinically Isolated Syndrome
Interventions: Ocrelizumab; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Psychotic Disorders, Prodromal Symptoms, Prodromal Schizophrenia, Psychosis, Family
Interventions: Family Focused Therapy for Clinical High Risk Youth (FFT-CHR), Enhanced Care (EC); Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 13 Years to 25 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 6
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 3 more

Conditions: Contraception, Reproductive Behavior, Contraception Behavior
Interventions: Control arm: Existing educational website, Advancing Access Website; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Liver Transplantation, Liver Diseases
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 70 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 8
States / cities: Los Angeles, California • Palo Alto, California • San Francisco, California + 5 more

Conditions: Gynecologic Cancer
Interventions: Digital Health Mobile App, Virtual Support Group, Health Coaching, FitBit, Handouts; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm
Interventions: Physical function assessment, Self-reported Assessments and Questionnaires, Surgery (Standard of Care, Non-Interventional); Other · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 2
States / cities: San Francisco, California • Boston, Massachusetts

Conditions: NAFLD, NAFLD-HIV, Hiv
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2031
U.S. locations: 8
States / cities: Tuscaloosa, Alabama • La Jolla, California • San Francisco, California + 5 more

Conditions: Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma, Recurrent Malignant Solid Neoplasm, Refractory Alveolar Rhabdomyosarcoma, Refractory Ewing Sarcoma, Refractory Lymphoma, Refractory Malignant Solid Neoplasm
Interventions: Elimusertib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 12 Months to 30 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 28
States / cities: Birmingham, Alabama • Los Angeles, California • Orange, California + 24 more

Conditions: Polycystic Ovary Syndrome, Obstructive Sleep Apnea
Interventions: Continuous Positive Airway Pressure Device (CPAP), Delayed Continuous Positive Airway Pressure Device (CPAP); Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: San Francisco, California

About this UCSF institution page

What this page lists: ClinicalTrials.gov records that list UCSF in San Francisco, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at UCSF

Filter and sort this campus

Live official records

Ropivacaine and Fentanyl for Labor Epidural Initiation

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Mediators of Atherosclerosis in South Asians Living in America

Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset

Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial

Patient-centered Information on Permanent Contraception

Social & Contextual Impact on Children Undergoing Liver Transplantation

Exercise and Movement to Enhance Resiliency in Cancer Patients

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial

About this UCSF institution page